General Cannabis Corp Stock Performance
| CANN Stock | USD 0.04 0 4.05% |
The company retains a Market Volatility (i.e., Beta) of -2.27, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning General Cannabis are expected to decrease by larger amounts. On the other hand, during market turmoil, General Cannabis is expected to outperform it. At this point, General Cannabis Corp has a negative expected return of -0.24%. Please make sure to check out General Cannabis' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if General Cannabis Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days General Cannabis Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 755.8 K | |
| Total Cashflows From Investing Activities | -978.7 K |
General |
General Cannabis Relative Risk vs. Return Landscape
If you would invest 5.00 in General Cannabis Corp on September 3, 2024 and sell it today you would lose (1.45) from holding General Cannabis Corp or give up 29.0% of portfolio value over 90 days. General Cannabis Corp is currently does not generate positive expected returns and assumes 7.6353% risk (volatility on return distribution) over the 90 days horizon. In different words, 67% of otc stocks are less volatile than General, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
General Cannabis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for General Cannabis' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as General Cannabis Corp, and traders can use it to determine the average amount a General Cannabis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0313
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CANN |
Estimated Market Risk
| 7.64 actual daily | 68 68% of assets are less volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average General Cannabis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of General Cannabis by adding General Cannabis to a well-diversified portfolio.
General Cannabis Fundamentals Growth
General OTC Stock prices reflect investors' perceptions of the future prospects and financial health of General Cannabis, and General Cannabis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on General OTC Stock performance.
| Return On Equity | -0.73 | |||
| Return On Asset | -0.0299 | |||
| Profit Margin | (0.59) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 35.32 M | |||
| Shares Outstanding | 114.17 M | |||
| Price To Earning | (0.58) X | |||
| Price To Book | 2.67 X | |||
| Price To Sales | 1.23 X | |||
| Revenue | 5.93 M | |||
| EBITDA | (6.6 M) | |||
| Cash And Equivalents | 1.07 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5.91 M | |||
| Debt To Equity | 0.99 % | |||
| Book Value Per Share | 0.08 X | |||
| Cash Flow From Operations | (2.65 M) | |||
| Earnings Per Share | (0.09) X | |||
| Total Asset | 22.02 M | |||
| Retained Earnings | (33.4 M) | |||
| Current Asset | 1.42 M | |||
| Current Liabilities | 17.93 M | |||
About General Cannabis Performance
By examining General Cannabis' fundamental ratios, stakeholders can obtain critical insights into General Cannabis' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that General Cannabis is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Trees Corporation provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. Trees Corporation was incorporated in 2013 and is headquartered in Denver, Colorado. GENERAL CANNABIS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 77 people.Things to note about General Cannabis Corp performance evaluation
Checking the ongoing alerts about General Cannabis for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for General Cannabis Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| General Cannabis generated a negative expected return over the last 90 days | |
| General Cannabis has high historical volatility and very poor performance | |
| General Cannabis has some characteristics of a very speculative penny stock | |
| General Cannabis Corp currently holds 5.91 M in liabilities with Debt to Equity (D/E) ratio of 0.99, which is about average as compared to similar companies. General Cannabis Corp has a current ratio of 0.6, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist General Cannabis until it has trouble settling it off, either with new capital or with free cash flow. So, General Cannabis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like General Cannabis Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for General to invest in growth at high rates of return. When we think about General Cannabis' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 5.93 M. Net Loss for the year was (8.87 M) with profit before overhead, payroll, taxes, and interest of 1.49 M. | |
| General Cannabis Corp currently holds about 1.07 M in cash with (2.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 83.0% of General Cannabis shares are held by company insiders |
- Analyzing General Cannabis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether General Cannabis' stock is overvalued or undervalued compared to its peers.
- Examining General Cannabis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating General Cannabis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of General Cannabis' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of General Cannabis' otc stock. These opinions can provide insight into General Cannabis' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in General OTC Stock
General Cannabis financial ratios help investors to determine whether General OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in General with respect to the benefits of owning General Cannabis security.